Anna Buigues
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Nicotinamide mononucleotide supplementation improves oocyte developmental competence in different ovarian damage conditions.
Journal: American journal of obstetrics and gynecology
Published: October 03, 2024
Growth factor-loaded ovarian extracellular matrix hydrogels promote in vivo ovarian niche regeneration and enhance fertility in premature ovarian insufficiency preclinical models.
Journal: Acta biomaterialia
Published: April 23, 2024
Single intraovarian dose of stem cell- and platelet-secreted factors mitigates age-related ovarian infertility in a murine model.
Journal: American journal of obstetrics and gynecology
Published: September 28, 2022
The cyto-protective effects of LH on ovarian reserve and female fertility during exposure to gonadotoxic alkylating agents in an adult mouse model.
Journal: Human reproduction (Oxford, England)
Published: February 12, 2021
Disease-inducing potential of two leukemic cell lines in a xenografting model.
Journal: Journal of assisted reproduction and genetics
Published: December 04, 2020
Correction to: Diminished Ovarian Reserve Chemotherapy-Induced Mouse Model: A Tool for the Preclinical Assessment of New Therapies for Ovarian Damage.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: November 11, 2020
Stem cell-secreted factor therapy regenerates the ovarian niche and rescues follicles.
Journal: American journal of obstetrics and gynecology
Published: October 27, 2020
Pathways and factors regulated by bone marrow-derived stem cells in human ovarian tissue.
Journal: Fertility and sterility
Published: October 08, 2020
Diminished Ovarian Reserve Chemotherapy-Induced Mouse Model: A Tool for the Preclinical Assessment of New Therapies for Ovarian Damage.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: May 21, 2020
Diminished Ovarian Reserve Chemotherapy-Induced Mouse Model: A Tool for the Preclinical Assessment of New Therapies for Ovarian Damage.
Journal: Reproductive sciences (Thousand Oaks, Calif.)
Published: February 23, 2019
Last Updated: 09/26/2026